Van Kammen DP - Search Results

1

Clonidine improves memory function in schizophrenia independently from change in psychosis. Preliminary findings.

Fields RB, Van Kammen DP, Peters JL, Rosen J, Van Kammen WB, Nugent A, Stipetic M, Linnoila M. Fields RB, et al. Among authors: van kammen wb, van kammen dp. Schizophr Res. 1988 Nov-Dec;1(6):417-23. doi: 10.1016/0920-9964(88)90024-2. Schizophr Res. 1988. PMID: 3154529

2

Neuropeptide Y-like immunoreactivity in schizophrenia. Relationships with clinical measures.

Peters J, Van Kammen DP, Gelernter J, Yao J, Shaw D. Peters J, et al. Among authors: van kammen dp. Schizophr Res. 1990 Oct-Dec;3(5-6):287-94. doi: 10.1016/0920-9964(90)90012-v. Schizophr Res. 1990. PMID: 2178001

3

Clonidine treatment of schizophrenia: can we predict treatment response?

van Kammen DP, Peters JL, van Kammen WB, Rosen J, Yao JK, McAdam D, Linnoila M. van Kammen DP, et al. Among authors: van kammen wb. Psychiatry Res. 1989 Mar;27(3):297-311. doi: 10.1016/0165-1781(89)90145-5. Psychiatry Res. 1989. PMID: 2469097 Clinical Trial.

4

Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited.

van Kammen DP, Peters J, Yao J, van Kammen WB, Neylan T, Shaw D, Linnoila M. van Kammen DP, et al. Among authors: van kammen wb. Arch Gen Psychiatry. 1990 Feb;47(2):161-8. doi: 10.1001/archpsyc.1990.01810140061009. Arch Gen Psychiatry. 1990. PMID: 1689140

5

CSF chromogranin A-like immunoreactivity in schizophrenia. Assessment of clinical and biochemical relationships.

van Kammen DP, Peters J, Yao J, Neylan T, Beuger M, Pontius E, O'Connor DT. van Kammen DP, et al. Schizophr Res. 1991 Dec;6(1):31-9. doi: 10.1016/0920-9964(91)90018-m. Schizophr Res. 1991. PMID: 1723893

6

Sleep disturbance and computerized axial tomographic scan findings in former prisoners of war.

Peters J, van Kammen DP, van Kammen WB, Neylan T. Peters J, et al. Among authors: van kammen wb, van kammen dp. Compr Psychiatry. 1990 Nov-Dec;31(6):535-9. doi: 10.1016/0010-440x(90)90067-3. Compr Psychiatry. 1990. PMID: 2265537

7

CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal.

van Kammen DP, Peters J, van Kammen WB, Nugent A, Goetz KL, Yao J, Linnoila M. van Kammen DP, et al. Among authors: van kammen wb. Biol Psychiatry. 1989 Jun;26(2):176-88. doi: 10.1016/0006-3223(89)90021-8. Biol Psychiatry. 1989. PMID: 2472177

8

No effect of haloperidol on cerebrospinal fluid acetylcholinesterase in patients with schizophrenia.

Huff FJ, Reiter CT, Rosen J, Peters J, van Kammen DP. Huff FJ, et al. Among authors: van kammen dp. Biol Psychiatry. 1988 Oct;24(6):701-4. doi: 10.1016/0006-3223(88)90145-x. Biol Psychiatry. 1988. PMID: 3167152 No abstract available.

9

Decreased slow-wave sleep and enlarged lateral ventricles in schizophrenia.

van Kammen DP, van Kammen WB, Peters J, Goetz K, Neylan T. van Kammen DP, et al. Among authors: van kammen wb. Neuropsychopharmacology. 1988 Dec;1(4):265-71. Neuropsychopharmacology. 1988. PMID: 3251506

10

Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status.

McAllister CG, van Kammen DP, Rehn TJ, Miller AL, Gurklis J, Kelley ME, Yao J, Peters JL. McAllister CG, et al. Among authors: van kammen dp. Am J Psychiatry. 1995 Sep;152(9):1291-7. doi: 10.1176/ajp.152.9.1291. Am J Psychiatry. 1995. PMID: 7653683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters